Our Approach to Investing in Genomics and Biosciences
It’s hard to believe that it has been a year and a half since we updated our healthcare thesis, as a follow-up to our blog series with Union Square Ventures on the future of healthcare. While we are still spending time on digital health, we have been focusing more on genomics and biosciences as a means to […]
What’s our NPS as investors?
A few weeks ago, Forbes released their annual Midas List of Top Tech Investors, recognizing those investors who have backed unicorns and seen strong returns for their funds. For these investors, their success is partly due to the fact that they are good pickers and can see opportunities like Uber and Airbnb. But there’s more to […]